Free Trial

Korea Investment CORP Sells 49,522 Shares of Bath & Body Works, Inc. $BBWI

Bath & Body Works logo with Retail/Wholesale background

Key Points

  • Korea Investment CORP reduced its stake in Bath & Body Works by 25.0% in the first quarter, holding 148,364 shares worth approximately $4.5 million after selling 49,522 shares.
  • Several institutional investors have recently increased their positions in Bath & Body Works, with Victory Capital Management enhancing its stake by over 14,700% during the first quarter.
  • Bath & Body Works announced a quarterly dividend of $0.20 per share, representing an annualized yield of 2.6%, set to be paid on September 5th.
  • Need better tools to track Bath & Body Works? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Korea Investment CORP lowered its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 25.0% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 148,364 shares of the company's stock after selling 49,522 shares during the period. Korea Investment CORP owned 0.07% of Bath & Body Works worth $4,498,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Northern Trust Corp grew its holdings in Bath & Body Works by 12.7% during the first quarter. Northern Trust Corp now owns 2,389,781 shares of the company's stock worth $72,458,000 after purchasing an additional 269,508 shares during the period. Brooklyn Investment Group grew its holdings in Bath & Body Works by 394.9% during the first quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock worth $82,000 after purchasing an additional 2,152 shares during the period. Fox Run Management L.L.C. raised its holdings in Bath & Body Works by 264.3% in the 1st quarter. Fox Run Management L.L.C. now owns 72,189 shares of the company's stock valued at $2,189,000 after acquiring an additional 52,372 shares during the period. Boston Partners raised its holdings in Bath & Body Works by 289.7% in the 1st quarter. Boston Partners now owns 937,024 shares of the company's stock valued at $28,292,000 after acquiring an additional 696,555 shares during the period. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Bath & Body Works by 9,569.1% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 11,893 shares of the company's stock valued at $361,000 after acquiring an additional 11,770 shares during the period. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 6.9%

BBWI stock traded down $2.18 during mid-day trading on Thursday, hitting $29.37. The stock had a trading volume of 13,649,250 shares, compared to its average volume of 5,168,736. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The firm has a market capitalization of $6.21 billion, a P/E ratio of 7.82, a P/E/G ratio of 1.05 and a beta of 1.54. The firm has a fifty day simple moving average of $30.58 and a 200 day simple moving average of $30.90.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.36 by $0.01. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. During the same period last year, the company posted $0.37 EPS. The company's revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is currently 21.33%.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Telsey Advisory Group reissued an "outperform" rating and issued a $38.00 price target on shares of Bath & Body Works in a report on Thursday. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Citigroup cut their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a report on Tuesday, August 19th. The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. Finally, Morgan Stanley cut their price objective on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $42.53.

Check Out Our Latest Stock Analysis on Bath & Body Works

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

See Also

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines